Benzinga | Aug 5, 2020 04:18PM EDT

Global Blood Therapeutics Q2 EPS $(0.86) Beats $(1.15) Estimate, Sales $31.50M Beat $18.81M Estimate

Global Blood Therapeutics (NASDAQ:GBT) reported quarterly losses of $(0.86) per share which beat the analyst consensus estimate of $(1.15) by 25.22 percent. This is a 14.85 percent increase over losses of $(1.01) per share from the same period last year. The company reported quarterly sales of $31.50 million which beat the analyst consensus estimate of $18.81 million by 67.47 percent.